Study guide

Ciliary body and aqueous secretion

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Ciliary body and aqueous secretion

Key Takeaways Explain This Topic AI

The ciliary epithelium forms aqueous through active transport with additional diffusion and ultrafiltration.

Aqueous secretion varies with physiology and treatment rather than remaining fixed throughout the day.

Aqueous composition and blood–aqueous barrier function depend on epithelial and vascular anatomy.

Last updated: October 2026

Intraocular pressure (IOP) is the fundamental modifiable risk factor in the pathogenesis and management of glaucomatous optic neuropathy. Homeostatic regulation of IOP is achieved through a dynamic equilibrium between the rate of aqueous humour synthesis by the ciliary body and the rate of aqueous egress through conventional trabecular and unconventional uveoscleral outflow pathways. Mastering the biophysical mechanisms governing aqueous turnover, the hydrodynamic principles expressed in the Goldmann equation, and the mechanical sources of error in tonometry is essential for the European Board of Ophthalmology Diploma (EBOD) examination.

1. Anatomy of the Ciliary Body & Aqueous Secretion

The ciliary body is an asymmetrical ring-shaped structure forming the intermediate portion of the uveal tract, extending from the scleral spur anteriorly to the ora serrata posteriorly. In sagittal section, it presents a triangular profile subdivided into two distinct anatomical zones:

Pars Plicata (Corona Ciliaris): The anterior 2.0 mm 2.0\text{ mm} 2.0 mm of the ciliary body, bearing 70 to 80 70\text{ to }80 70 to 80 radially oriented, highly vascularized ridges termed ciliary processes . Each process measures approximately 2.0 mm 2.0\text{ mm} 2.0 mm in length, 0.5 mm 0.5\text{ mm} 0.5 mm in width, and 1.0 mm 1.0\text{ mm} 1.0 mm in height. The extensive microscopic folding of these processes creates a massive total secretory surface area of approximately 6.0 cm 2 6.0\text{ cm}^2 6.0 cm 2 , functioning as the specialized factory for aqueous humour production.

Pars Plana (Orbiculus Ciliaris): The posterior 4.0 mm 4.0\text{ mm} 4.0 mm of the ciliary body, presenting a relatively smooth, avascular inner surface extending to the scalloped margin of the ora serrata. It provides an anatomically safe surgical corridor for posterior segment entry ( 3.0 to 3.5 mm 3.0\text{ to }3.5\text{ mm} 3.0 to 3.5 mm posterior to the limbus in pseudophakic/aphakic eyes; 3.5 to 4.0 mm 3.5\text{ to }4.0\text{ mm} 3.5 to 4.0 mm in phakic adult eyes).

The Double Epithelial Layer & Blood-Aqueous Barrier

The inner surface of the ciliary processes is lined by a specialized bilayered epithelium , reflecting its embryological derivation from the two layers of the neuroectodermal optic cup:

Pigmented Ciliary Epithelium (PCE): The outer epithelial layer, directly continuous with the retinal pigment epithelium (RPE). Its basal lamina rests against the highly vascularized ciliary stroma. The cells are cuboidal, filled with dense melanin granules, and display deep basal infoldings.

Non-Pigmented Ciliary Epithelium (NPCE): The inner epithelial layer facing the posterior chamber, directly continuous with the neurosensory retina. Its basal lamina forms the internal limiting membrane of the ciliary body, facing the aqueous humour of the posterior chamber. Cells are tall, columnar, filled with abundant mitochondria, rough endoplasmic reticulum, and complex basolateral membrane interdigitations that house metabolic ion-translocating enzymes.

Cellular Orientation & Functional Syncytium: Because the optic cup invaginates during embryogenesis, the apical surfaces of the PCE and NPCE abut each other ( apex-to-apex orientation ). Extensive gap junctions (predominantly composed of connexin 43) link their opposing apical membranes, allowing ions, metabolites, and second messengers to pass freely between layers, converting the bilayer into a coordinated single functional transport unit.

Blood–aqueous barrier : Tight junctions in non-pigmented ciliary epithelium and iris vascular endothelium restrict uncontrolled entry of protein and cells. Inflammation can disrupt these barriers and produce cells and flare.

Biochemical Mechanisms of Aqueous Production

Aqueous humour is synthesized at an average physiological rate of 2.0 to 2.5 μ L/min 2.0\text{ to }2.5\,\mu\text{L/min} 2.0 to 2.5 μ L/min in young healthy adults, turning over the anterior chamber volume (approximately 200 to 250 μ L 200\text{ to }250\,\mu\text{L} 200 to 250 μ L ) at a rate of 1.0 to 1.5 % 1.0\text{ to }1.5\% 1.0 to 1.5% per minute (a characteristic replacement time of roughly 90–100 minutes, not literal complete clearance of every molecule). Aqueous production relies on three physiological mechanisms:

Active Secretion ( 80 to 90 % 80\text{ to }90\% 80 to 90% of Total Production): The primary, energy-dependent driving force, completely independent of hydrostatic pressure gradients. Active solute transport is driven by two enzymatic systems operating within the basolateral membranes and cytoplasm of the NPCE:

Na + / K + \text{Na}^+/\text{K}^+ Na + / K + -ATPase: Located predominantly along the basolateral interdigitations of the NPCE, this pump actively extrudes 3 Na + 3\,\text{Na}^+ 3 Na + ions into the lateral intercellular spaces and posterior chamber in exchange for 2 K + 2\,\text{K}^+ 2 K + ions entering the cell, utilizing ATP hydrolysis.

Carbonic Anhydrase II (CA-II): Cytoplasmic and membrane-bound carbonic anhydrase catalyzes the reversible hydration of carbon dioxide: CO 2 + H 2 O ⇌ CA-II H 2 CO 3 ⇌ Spontaneous H + + HCO 3 − \text{CO}_2 + \text{H}_2\text{O} \xrightleftharpoons{\text{CA-II}} \text{H}_2\text{CO}_3 \xrightleftharpoons{\text{Spontaneous}} \text{H}^+ + \text{HCO}_3^- CO 2 ​ + H 2 ​ O CA-II ​ H 2 ​ CO 3 ​ Spontaneous ​ H + + HCO 3 − ​ The generated HCO 3 − \text{HCO}_3^- HCO 3 − ​ anions are transported across the basolateral membrane into the posterior chamber via anion exchangers. Intracellular H + \text{H}^+ H + is exchanged for stromal Na + \text{Na}^+ Na + via the Na + / H + \text{Na}^+/\text{H}^+ Na + / H + antiport.

The net directional movement of Na + \text{Na}^+ Na + , Cl − \text{Cl}^- Cl − , and HCO 3 − \text{HCO}_3^- HCO 3 − ​ into the intercellular clefts generates an osmotic gradient that passively draws water from the ciliary stroma across aquaporin-1 ( AQP1 ) channels into the posterior chamber.

Ultrafiltration ( 10 to 20 % 10\text{ to }20\% 10 to 20% ): Hydrostatic pressure within the fenestrated ciliary microvasculature forces water and low-molecular-weight crystalloids across the capillary endothelium into the stroma, governed by the balance of transcapillary Starling forces (hydrostatic pressure difference versus plasma oncotic pressure difference).

Simple Diffusion (Minor Contribution): Passive, non-energy-dependent movement of small, lipid-soluble molecules down their concentration gradients across cell membranes.

Aqueous Composition vs. Blood Plasma

Aqueous humour is not a simple protein-free filtrate of blood plasma; active epithelial transport yields a unique physiological microenvironment:

Physiological Parameter Blood Plasma Aqueous Humour Clinical & Functional Significance

Total Protein 60 – 80 g/L 60–80\text{ g/L} 60–80 g/L 0.1 – 0.2 g/L 0.1–0.2\text{ g/L} 0.1–0.2 g/L ( < 0.2 % < 0.2\% < 0.2% ) Minimizes light scatter to maintain optical clarity (Tyndall-negative); low protein content contributes to optical clarity; the aqueous is not immunoglobulin-free.

Ascorbic Acid (Vitamin C) 0.05 mmol/L 0.05\text{ mmol/L} 0.05 mmol/L 1.0 – 1.5 mmol/L 1.0–1.5\text{ mmol/L} 1.0–1.5 mmol/L ( 15 – 20 × 15–20\times 15–20 × ) Actively transported by sodium-dependent vitamin C transporter 2 (SVCT2); scavenges UV-induced reactive oxygen species (ROS) to protect corneal endothelium and lens.

Lactic Acid 1.0 – 1.5 mmol/L 1.0–1.5\text{ mmol/L} 1.0–1.5 mmol/L 3.5 – 4.5 mmol/L 3.5–4.5\text{ mmol/L} 3.5–4.5 mmol/L ( 2.5 – 3 × 2.5–3\times 2.5–3 × ) Derived from anaerobic glycolysis in the avascular crystalline lens and corneal endothelium.

Glucose 5.0 – 6.0 mmol/L 5.0–6.0\text{ mmol/L} 5.0–6.0 mmol/L 3.0 – 4.0 mmol/L 3.0–4.0\text{ mmol/L} 3.0–4.0 mmol/L ( ≈ 70 % \approx 70\% ≈ 70% ) Provides primary metabolic fuel for avascular anterior segment structures.

Chloride ( Cl − \text{Cl}^- Cl − ) & Bicarbonate ( HCO 3 − \text{HCO}_3^- HCO 3 − ​ ) 100 mEq/L 100\text{ mEq/L} 100 mEq/L / 24 mEq/L 24\text{ mEq/L} 24 mEq/L 125 mEq/L 125\text{ mEq/L} 125 mEq/L / 21 mEq/L 21\text{ mEq/L} 21 mEq/L Primary osmotic counter-ions accompanying active sodium transport across the NPCE.

Osmolarity 295 mOsm/kg 295\text{ mOsm/kg} 295 mOsm/kg 305 mOsm/kg 305\text{ mOsm/kg} 305 mOsm/kg Slightly hyperosmotic, driving fluid movement into the anterior and posterior chambers.

Circadian Rhythm of Aqueous Synthesis & IOP

Aqueous humour production exhibits a pronounced diurnal variation controlled by endogenous circadian clocks and circulating catecholamines acting on NPCE β 2 \beta_2 β 2 ​ -adrenergic receptors:

Daytime secretion: Aqueous flow is generally greater during waking hours than during sleep.

Nocturnal secretion: Flow commonly falls during sleep; the magnitude and timing vary with the patient and measurement conditions.

IOP across the day: Lower nocturnal production does not guarantee lower pressure. Posture, episcleral venous pressure, outflow and treatment contribute. A clinic measurement can miss a peak; interpret diurnal testing with the posture and device recorded.

Sections you finish are checked off in the contents.

  • Up Next
  • Outflow and the Goldmann pressure model
  • Continue learning